Matches in Nanopublications for { ?s ?p ?o <http://www.tkuhn.ch/bel2nanopub/RAqiceYbBr2S8z_MekhVtZZEQC9BfBHcFr-YFQ1WN9ye0#provenance>. }
Showing items 1 to 11 of
11
with 100 items per page.
- _3 label "Selventa" provenance.
- large_corpus.bel title "BEL Framework Large Corpus Document" provenance.
- large_corpus.bel description "Approximately 61,000 statements." provenance.
- large_corpus.bel version "20131211" provenance.
- large_corpus.bel authoredBy _3 provenance.
- assertion wasDerivedFrom large_corpus.bel provenance.
- assertion wasDerivedFrom _2 provenance.
- assertion hadPrimarySource 20716686 provenance.
- _2 wasQuotedFrom 20716686 provenance.
- _2 value "Treatment with the phosphodiesterase (PDE) inhibitors rolipram (a cAMP-specific PDE IV inhibitor), 3-isobutyl-1-methylxanthine (IBMX), erythro-9-(2- hydroxy-3-nonyl)-adenine (EHNA, a PDE II inhibitor), and the b- adrenergic receptor (b-AR) agonist isoproterenol, which increase the intracellular cAMP level, also inhibited the nuclear export of HDAC5 (Fig. 1C andD)." provenance.
- large_corpus.bel rights "Copyright (c) 2011-2012, Selventa. All rights reserved." provenance.